Abstract:Abstract Background Fast Fixation is necessary to study real-time protein-protein interactions under physiological conditions. Fast formaldehyde cross-linking can fix transient and weak protein interactions, thereby reducing the number of false negatives but producing great complexity. To reduce this complexity, immunoaffinity purification can Fish out complexes that include particular target proteins, but affinity-based co-purification has a limited capacity to eliminate nonspecific binding to beads and/or antibodies. To Filter out these complexes, SDS-PAGE is used to disrupt non-covalent bonds, thereby eliminating uncross-linked complexes and simultaneously providing molecular weight information for identification. Results We described a 4 F strategy to help improve real-time ligands discovery based on formaldehyde crosslinking, immunoprecipitation and SDS-PAGE separation: Fast Fix, Fish, and Filter, using albumin interactome as an example. The use of gel excision without staining makes this strategy comprehensive and sensitive. The target protein must be identified in the same slice as its ligands. The ligands must be identified in slices for the experimental group but not in the corresponding control slices. Only proteins that appear in the range of molecular weights equal to or greater than the sum of the proteins’ theoretical molecular weights, together with the target, are considered ligands. In this study, 5 s of cross-linking with 10% formaldehyde was achieved in human blood. The use of this strategy identified 35 ligands for albumin. Comparison with four major previous studies of the albuminome revealed that 68.57% of the 35 ligands identified in our study were identified in these other studies. Conclusions Fast cross-linking was achieved. The 4 F strategy can be used to identify real-time in situ interactions without prior intervention and to comprehensively identify ligands of particular target proteins with fewer false positives.

A Novel Strategy for Proteome-wide Ligand Screening Using Cross-linked Phage Matrices

New Tetrapeptide Ligands Designed for Antibody Purification with Biomimetic Chromatography: Molecular Simulation and Experimental Validation

Tetrapeptide Ligands Screening for Antibody Separation and Purification by Molecular Simulation and Experimental Verification

Phage Display of Random Combinatorial Libraries of Ig-Binding Mono-Domains of Protein A and Protein L and Ig Affinity Screening

Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays.

Function-based High-Throughput Screening for Antibody Antagonists and Agonists Against G Protein-Coupled Receptors

Cell-based Screening of Phage Antibody Library

Semi-Automated Cell Panning for Efficient Isolation of FGFR3-Targeting Antibody

An image-based Abplex method for high-throughput GPCRs antibody discovery

Selecting peptide ligands of microcystin-LR from phage displayed random libraries

Subtractive panning for the isolation of monoclonal PEPITEM peptide antibody by phage display

Fast fixing and comprehensive identification to help improve real-time ligands discovery based on formaldehyde crosslinking, immunoprecipitation and SDS-PAGE separation

Modification of phage display technique for improved screening of high-affinity binding peptides

A protein microarray prepared with phage-displayed antibody clones.

Development of a Phage Display Panning Strategy Utilizing Crude Antigens: Isolation of MERS-CoV Nucleoprotein human antibodies

A phage-displayed disulfide constrained peptide discovery platform yields novel human plasma protein binders

Efficient Hapten-Specific Biopanning Strategy Based on the Fe3O4@ENR-Functionalized Core-Shell Magnetic Nanoparticles

A biosensor-based phage display selection method for automated, high-throughput Nanobody discovery

Discovery of antibodies targeting multipass transmembrane proteins using a suspension cell-based evolutionary approach

A compact phage display human scFv library for selection of antibodies to a wide variety of antigens

Omniligase-1-Mediated Phage-Peptide Library Modification and Insulin Engineering